Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension
Phase 3 extension data show denifanstat, an oral fatty acid synthase inhibitor, sustained acne improvement through 52 weeks — the longest durability readout for the agent to date.